Opportunity

Simpler Grants.gov #O-BJA-2026-172680

Competitive Grants for DNA Lab Capacity Enhancement and Backlog Reduction

Buyer

Bureau of Justice Assistance

Posted

September 23, 2026

Respond By

November 03, 2026

Identifier

O-BJA-2026-172680

NAICS

541380

This opportunity is a competitive grant program from the Bureau of Justice Assistance (BJA) aimed at enhancing the capacity of publicly funded forensic DNA laboratories. - Government Buyer: - Bureau of Justice Assistance (BJA), U.S. Department of Justice - Purpose and Scope: - Funding to increase the capacity and efficiency of state and local government forensic DNA labs - Supports processing DNA samples for entry into the Combined DNA Index System (CODIS) - Prioritizes implementation of Rapid DNA technology in booking stations - Products/Services Requested: - No specific OEMs, vendors, products, or part numbers are mentioned - Focus is on services to enhance DNA lab capacity and reduce backlogs - Unique or Notable Requirements: - Emphasis on evidence-based criminal justice improvements - Eligible applicants include a wide range of state and local government entities (e.g., counties, cities, townships, special districts) - Formula funding will be announced separately; this notice is for competitive funding only - OEMs: - No OEMs are specified in the solicitation

Description

This notice of funding opportunity (NOFO) is for the BJA FY 2026 DNA Capacity Enhancement for Backlog Reduction (CEBR) Competitive Grants Program. The program aims to increase the capacity of states and local government crime laboratories to process DNA samples for entry into the Combined DNA Index System (CODIS). It focuses on maximizing the use of DNA technology to strengthen evidence-based criminal justice responses, prioritizing increased capacity and efficiency of publicly funded forensic DNA labs and implementing Rapid DNA in booking stations. The program is competitive funding only, with formula funding to be announced later. Eligible agencies may apply for both competitive and formula funding.

View original listing